Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Benjamin, Caulier"'
Autor:
Gunnar Kvalheim, Kristina Lindemann, Ben Davidson, Line Bjorge, Else Marit Inderberg, Sébastien Wälchli, Emmet McCormack, Katrin Kleinmanns, David J Warren, Erik Rokkones, Martine Lode, Nicholas P Casey, Christopher Forcados, Pascal F Gelebart, Sandy Joaquina, Emmanuelle Benard, Fatemeh Kaveh, Benjamin Caulier, Christiane Helgestad Gjerde, Elvira García de Jalón, Marit Renee Myhre
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background Ovarian cancer (OC) is the leading cause of death from gynecologic malignancies in the Western world. Contributing factors include a high frequency of late-stage diagnosis, the development of chemoresistance, and the evasion of host immune
Externí odkaz:
https://doaj.org/article/162ad2ed429c4bd1b84eb0e5bfee44ad
Autor:
Sandy Joaquina, Christopher Forcados, Benjamin Caulier, Else Marit Inderberg, Sébastien Wälchli
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Adoptive transfer of T cells modified to express chimeric antigenic receptors (CAR) has emerged as a solution to cure refractory malignancies. However, although CAR T cell treatment of haematological cancers has now shown impressive improvement in ou
Externí odkaz:
https://doaj.org/article/e860b903ad7b41a192e250d55a5b49ad
Autor:
Benjamin Caulier, Gaëlle Stofleth, Dalil Hannani, Mélanie Guidetti, Véronique Josserand, David Laurin, Jadwiga Chroboczek, Pascal Mossuz, Dominique Plantaz
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 181-190 (2021)
Intensive systemic chemotherapy is the gold standard of acute myeloid leukemia (AML) treatment and is associated with considerable off-target toxicities. Safer and targeted delivery systems are thus urgently needed. In this study, we evaluated a viru
Externí odkaz:
https://doaj.org/article/32dbb671c52b4ce79a03a5d7832faa1b
Autor:
Dalil Hannani, Estelle Leplus, David Laurin, Benjamin Caulier, Caroline Aspord, Natacha Madelon, Ekaterina Bourova-Flin, Christian Brambilla, Elisabeth Brambilla, Anne-Claire Toffart, Karine Laulagnier, Laurence Chaperot, Joël Plumas
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 1897 (2023)
The purpose of immune checkpoint inhibitor (ICI)-based therapies is to help the patient’s immune system to combat tumors by restoring the immune response mediated by CD8+ cytotoxic T cells. Despite impressive clinical responses, most patients do no
Externí odkaz:
https://doaj.org/article/1ab0e2c758da45e0a5b3acd58c5185e6
Autor:
Christopher Forcados, Sandy Joaquina, Nicholas Paul Casey, Benjamin Caulier, Sébastien Wälchli
Publikováno v:
Cells, Vol 11, Iss 9, p 1454 (2022)
The manufacture of efficacious CAR T cells represents a major challenge in cellular therapy. An important aspect of their quality concerns energy production and consumption, known as metabolism. T cells tend to adopt diverse metabolic profiles depend
Externí odkaz:
https://doaj.org/article/3e5115d1a4954d548fda248c30a65dce
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 9, p 4320 (2021)
Chimeric antigen receptor (CAR) therapy is a promising modality for the treatment of advanced cancers that are otherwise incurable. During the last decade, different centers worldwide have tested the anti-CD19 CAR T cells and shown clinical benefits
Externí odkaz:
https://doaj.org/article/7024ac5f94354039a6e8041460f8c364
Autor:
Dominique Plantaz, Dalil Hannani, Jadwiga Chroboczek, Benjamin Caulier, Mélanie Guidetti, Gaëlle Stofleth, Véronique Josserand, David Laurin, Pascal Mossuz
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 181-190 (2021)
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2020, ⟨10.1016/j.omtm.2020.11.009⟩
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2020, ⟨10.1016/j.omtm.2020.11.009⟩
Molecular Therapy. Methods & Clinical Development
Intensive systemic chemotherapy is the gold standard of acute myeloid leukemia (AML) treatment and is associated with considerable off-target toxicities. Safer and targeted delivery systems are thus urgently needed. In this study, we evaluated a viru
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2383
Transcription factors (TFs) are key players in the control of gene expression and consequently all major cellular process, ranging from cell fate determination to cell cycle control and response to the environment.In particular cases, their ectopic e
Publikováno v:
Methods in Molecular Biology ISBN: 9781071617519
Transcription factors (TFs) are key players in the control of gene expression and consequently all major cellular process, ranging from cell fate determination to cell cycle control and response to the environment.In particular cases, their ectopic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ab14292a9e8422d28196c176b20b9d4
https://doi.org/10.1007/978-1-0716-1752-6_19
https://doi.org/10.1007/978-1-0716-1752-6_19
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4320, p 4320 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Chimeric antigen receptor (CAR) therapy is a promising modality for the treatment of advanced cancers that are otherwise incurable. During the last decade, different centers worldwide have tested the anti-CD19 CAR T cells and shown clinical benefits